EYPT
EyePoint Pharmaceuticals Inc
Price:  
5.67 
USD
Volume:  
557,917.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

EYPT WACC - Weighted Average Cost of Capital

The WACC of EyePoint Pharmaceuticals Inc (EYPT) is 6.2%.

The Cost of Equity of EyePoint Pharmaceuticals Inc (EYPT) is 8.80%.
The Cost of Debt of EyePoint Pharmaceuticals Inc (EYPT) is 5.00%.

Range Selected
Cost of equity 5.90% - 11.70% 8.80%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 4.8% - 7.7% 6.2%
WACC

EYPT WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.45 1.22
Additional risk adjustments 0.0% 0.5%
Cost of equity 5.90% 11.70%
Tax rate 26.20% 27.00%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 4.8% 7.7%
Selected WACC 6.2%